The answer is that new versions of Web APIs, such as the DOM, are not needed to make them usable from Wasm; the existing ...
Mylan’s long-awaited rival for Teva’s blockbuster multiple sclerosis drug Copaxone has been approved in the US, putting a large chunk of the Israeli firm’s revenues at risk. The timing could not have ...